Wichtige Widerstände: Wo NVO jetzt scheitern könnte

AI-generated source summary

The analysis focuses on Novo Nordisk (NVO) with a bearish outlook on the 4-hour timeframe. The current price is observed at 48.03. The predicted target price is 21.82. The invalidation level, or fail bound, is set at 56.85. The analysis suggests that the price is currently in a corrective rally within a larger downtrend. The structure indicates a potential for a five-wave move downwards, with the third wave being the primary focus. Key support levels are identified around 41.70 and the swing low of 41.50. The resistance zone for a potential wave 2 bounce is between 50.00 and 56.85. If the price breaks above 56.85, the bearish outlook would be invalidated, and the analysis would need to be re-evaluated, possibly indicating a broader corrective rally. The immediate target for the bearish move is around 21.82, with further potential downside towards 17.40.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   29 Jun 2026, 16:14 UTC

   The analyst published the original source item.

2. Source recorded by Tahlil Plus

   15 Jul 2026, 15:02 UTC

   The public source was preserved as the evidence record for this case.

3. Market predictions extracted

   27 Jul 2026, 02:24 UTC

   1 eligible signal linked to this case.

4. Outcome tracking started

   27 Jul 2026, 02:24 UTC

   Tahlil Plus began monitoring the extracted predictions.

5. Source processing completed

   27 Jul 2026, 02:24 UTC

   Source analysis and structured extraction completed.

6. Live evaluation in progress

   01 Aug 2026, 01:47 UTC

   1 signal remains active.